These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Lipid-reducing basic diet and serum fatty acid levels]. Reuter W. Z Gesamte Inn Med; 1980 Sep 15; 35(18):701-6. PubMed ID: 7445612 [Abstract] [Full Text] [Related]
6. [Clinico-experimental long-term study on the combined effect of clofibrin and nicotinic acid on abnormal fatty acid patterns in lipid metabolism disorders in the aged]. Reuter W. Z Alternsforsch; 1983 Sep 15; 38(1):57-62. PubMed ID: 6405546 [Abstract] [Full Text] [Related]
11. Plasma cholesterol esterification rate in type IV hyperlipoproteinemia. Relation to bile acid kinetics and triglyceride metabolism. Angelin B, Einarsson K, Leijd B, Wallentin L. J Lab Clin Med; 1981 Apr 15; 97(4):502-10. PubMed ID: 7205058 [Abstract] [Full Text] [Related]
12. [Fatty acid metabolism in primary hyperlipoproteinemia]. Reuter W. Z Gesamte Inn Med; 1979 Oct 15; 34(20):suppl 287-9. PubMed ID: 398634 [No Abstract] [Full Text] [Related]
13. Changes in fatty acid composition of the single platelet phospholipids induced by pantethine treatment. Gensini GF, Prisco D, Rogasi PG, Matucci M, Neri Serneri GG. Int J Clin Pharmacol Res; 1985 Oct 15; 5(5):309-18. PubMed ID: 4066081 [Abstract] [Full Text] [Related]
14. Effects of postnatal age and diet on the fatty acid composition of plasma lipid fractions in preterm infants. Pita ML, Girón MD, Pérez-Ayala M, DeLucchi C, Martínez Valverde A, Gil A. Clin Physiol Biochem; 1989 Oct 15; 7(5):238-48. PubMed ID: 2805572 [Abstract] [Full Text] [Related]
15. [Apolipoprotein E and activity of cholesterol esters transport in type IIA and IIB hyperlipoproteinemia]. Tvorogova MG, Rozhkova TA, Semenova OA, Lupanov VP, Nuraliev EIu, Kukharchuk VV, Titov VN. Ter Arkh; 1997 Oct 15; 69(12):30-3. PubMed ID: 9503530 [Abstract] [Full Text] [Related]
16. [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis]. Jäger E, Sinzinger H, Widhalm K, Kaliman J, Höfer R. Wien Klin Wochenschr; 1982 Sep 03; 94(16):421-5. PubMed ID: 7147981 [Abstract] [Full Text] [Related]
17. [Effects of fenofibrate in four types of hyperlipoproteinaemia and on apoproteins A and B in type IIa HLP (author's transl)]. Micheli H, Pometta D, Gustafson A. Nouv Presse Med; 1980 Dec 22; 9(49):3759-62. PubMed ID: 7208343 [Abstract] [Full Text] [Related]
18. Serum lipoprotein fatty acid patterns in various types of familiar combined hyperlipidemia. Hrebícek J, Chmela Z, Skottová N, Bartek J, Vecera R. Acta Univ Palacki Olomuc Fac Med; 1995 Dec 22; 139():19-23. PubMed ID: 8686553 [Abstract] [Full Text] [Related]
19. Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study. Domingo AJ, Gutiérrez JA, Menéndez JA, Micó L, Muñoz M, de Oya M. Clin Ther; 1980 Dec 22; 3(3):219-26. PubMed ID: 7459931 [Abstract] [Full Text] [Related]